Role of isoniazid prophylaxis for prevention of tuberculosis in haemopoietic stem cell transplant recipients

Journal of the Pakistan Medical Association

Volumn 55, Issue 9, 2005, Pages 378-381

  Ahmed, Parvez ^a   Anwar, Masood ^a   Khan, Badshah ^a   Altaf, Chauhdry ^a   Ullah, Khalil ^a   Raza, Shahid ^a   Hussain, Iftikhar ^a  

^a National University of Medical Sciences   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; BUSULFAN; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETHAMBUTOL; FLUCONAZOLE; ISONIAZID; METHOTREXATE; PREDNISOLONE; PYRAZINAMIDE; RIFAMPICIN; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BETA THALASSEMIA; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DEATH; DEMOGRAPHY; DRUG EFFICACY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MYCOBACTERIUM TUBERCULOSIS; OPPORTUNISTIC INFECTION; PAKISTAN; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PREVALENCE; PROPHYLAXIS; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; ADULT; ANTIBIOTIC PROPHYLAXIS; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; ISONIAZID; MALE; PAKISTAN; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 31344464370     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. WHO Report 2004. Global tuberculosis control: Surveillance, Planning, Financing. Geneva World Health Organization 2004.
2. Country Profile: Pakistan; Global Tuberculosis control. WHO Report 2003, pp. 99-101.
3. Report of The First International Review Meeting. Practical Approach to Lung Health (PAL) Strategy. World Health Organization 2003;324:1-43.
4. Khan JA, Malik A. Tuberculosis in Pakistan: Are we losing the balttle? J Pak Med Assoc 2003;53:320-1.
5. Collins CH, Grange JM, Yates MD. Introduction: mycobacteria and mycobacterial disease. In Tuberculosis Bacteriology Organization and Practice. 2nd Edition. Butterworth Heinemann 1997 Oxford, pp. 1-11.
6. Kurzrock R, Zander A, Vellekoop L, Kanojia M, Luna M, Dicke K. Mycobacterial pulmonary infections after allogeneic bone marrow transplantation. Am J Med 1984;77:35-40.
7. Hughes WT. Mycobacterial infections in BMT recipients. Biol Blood Marrow Transplant 2000;6:359-60.
8. Ip MS, Yuen KY, Woo PC, Luk WK, Tsang KW, Lam WK, et al. Risk factors for pulmonary tuberculosis in bone marrow transplant recipients. Am J Respir Crit Care Med 1998;158:1173-7.
9. Martino R, Martinez C, Brunet S, Sureda A, Lopez R, Domingo-Albos A. Tuberculosis in bone marrow transplant recipients: report of two cases and review of literature. Bone Marrow Transplant 1996;18:809-12.
10. Yuen KY, Woo PC. Tuberculosis in blood and marrow transplant recipients. Hematol Oncol 2002;20:51-62.
11. Budak-Alpdogan T, TangAnn Y, Kalayoglu-Besisik S, Ratip S, Akan H, Barlar Z, et al. The frequency of tuberculosis in adult allogeneic stem cell transplant recipients in Turkey. Biol Blood Marrow Transplant 2000;6:370-4.
12. George B, Mathews V, Srivastava V, Srivastava A, Chandy M. Tuberculosis among allogeneic bone marrow transplant recipients in India. Bone Marrow Transplant 2001;27:973-5.
13. El-Agroudy AE, Refaie AF, Moussa OM, Ghoneim MA. Tuberculosis in Egyptian kidney transplant recipients: Study of clinical course and outcome. J Nephrol 2003;16:404-11.
14. Valencia ME, GU A, Diaz MA, Torres A, Lavilla P, Pintado V, et al. Clinical study of tuberculosis in immunocompromised patients. Rev Clin Esp 1989;184:352-6. (Abstract)
15. Barnes PF. Rapid diagnostic test for tuberculosis; progress but no gold standard (editorial) Am J Respir Crit Care Med 1997;155:1497-8.
16. Rapid diagnostic tests for tuberculosis; what is appropriate use? Am Thoracic Society Workshop. Am J Respir Crit Care Med 1997;155:1804-14.
17. Cohen RA, Muzaffar S, Schwarte D, Bashir S, Luke S, McGartland LP, et al. Diagnosis of pulmonary tuberculosis using PCR assays on sputum collected within 24 hours of hospital admission. Am J Respir Crit Care Med 1998;157:156-61.
18. Brugiere O, Vokurka M, Lecossier D, Mangiapan G, Amrane A, Milleron B, et al. Diagnosis of smear negative pulmonary tuberculosis using sequence capture polymerase chain reaction. Am J Respir Crit Care Med 1997;155:1478-81.
19. Horsburgh CR Jr, Feldman S, Ridzon R. Infectious Diseases Society of America: Practice Guidelines for the Treatment of Tuberculosis. Clin Infect Dis 2000;31:633-9.
20. Carosi G, Matteelli A. Prophylaxis for tuberculosis in Europe-ongoing research. Clin Infect Dis 1996;22 Suppl 1:555-60.
21. MacIntyre CR, Ansari MZ, Camie J, Hart WG No evidence for multiple-drug prophylaxis for tuberculosis compared with isoniazid alone in Southeast Asian refugees and migrants: completion and compliance are major determinants of effectiveness. Prev Med 2000;30:425-32.
22. Hemandez-Cruz B, Ponce-de-Leon-Rosales S, Sifuentes-Osornio J, Ponce-de-Leon-Garduno A, Diaz-Jouanen E. Tuberculosis prophylaxis in patients with steroid treatment and systemic rheumatic diseases. A case-control study. Clin Exp Rheumatol 1999;17:81-7.
23. Rose DN. Short-course prophylaxis against tuberculosis in HIV-infected persons. A decision and cost effectiveness analysis. Ann Intern Med 1998;129:779-86.